Valuation: Celltrion, Inc.

Capitalization 41,58300Cr 2.85TCr 2.42TCr 2.21TCr 2.09TCr 3.9TCr 2,68800Cr 3.93TCr 26TCr 10TCr 1,29100Cr 11TCr 10TCr 4,45700Cr P/E ratio 2026 *
32x
P/E ratio 2027 * 26.6x
Enterprise value 4.35TCr 2.98Cr 2.53Cr 2.31Cr 2.18Cr 4.07Cr 281.1Cr 4.11Cr 27Cr 11Cr 135.02Cr 11Cr 11Cr 466.16Cr EV / Sales 2026 *
8.16x
EV / Sales 2027 * 6.96x
Free-Float
70.87%
Yield 2026 *
0.39%
Yield 2027 * 0.42%
1 day-2.02%
1 week-1.05%
Current month-1.05%
1 month-1.78%
3 months-9.82%
6 months+14.75%
Current year+9.61%
1 week 1,94,700
Extreme 194700
2,06,500
1 month 1,93,600
Extreme 193600
2,12,000
Current year 1,87,700
Extreme 187700
2,51,000
1 year 1,44,615.38
Extreme 144615.3846
2,51,000
3 years 1,19,963.37
Extreme 119963.37
2,51,000
5 years 1,19,963.37
Extreme 119963.37
2,59,410.96
10 years 65,004.08
Extreme 65004.0844
3,41,497.26
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
President 50 13/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 01/04/2005
Director/Board Member 66 -
Change 5d. change 1-year change 3-years change Capi.($)
-2.02%-1.05%+29.45%+33.41% 2.85TCr
-0.66%+0.79%-15.44%-16.46% 4.34TCr
-1.54%+6.21%+32.29%+22.92% 3.47TCr
-0.49%+1.67%+238.37%+480.24% 3.01TCr
+0.04%+13.27%+16.58%-5.85% 2.98TCr
-6.96%+0.55%+424.83%+4,203.98% 1.45TCr
-3.04%+8.03% - - 1.47TCr
-0.41%+0.57%+131.18%+115.21% 1.25TCr
-0.64%+0.54%+5.74%-8.68% 1.23TCr
-1.10%+1.55%+40.95%+102.37% 1.21TCr
Average -1.68%+3.21%+100.44%+547.46% 2.33TCr
Weighted average by Cap. -1.40%+3.55%+79.52%+361.52%

Financials

2026 *2027 *
Net sales 5,32700Cr 364.56Cr 309.73Cr 283.46Cr 267.54Cr 499.05Cr 34TCr 503.46Cr 3.36TCr 1.31TCr 17TCr 1.37TCr 1.34TCr 57TCr 6,11300Cr 418.36Cr 355.44Cr 325.28Cr 307.02Cr 572.7Cr 40TCr 577.75Cr 3.86TCr 1.5TCr 19TCr 1.57TCr 1.54TCr 66TCr
Net income 1,37900Cr 94Cr 80Cr 73Cr 69Cr 129.2Cr 8.91TCr 130.34Cr 870.46Cr 339.33Cr 4.28TCr 354.08Cr 346.63Cr 15TCr 1,66800Cr 114.15Cr 97Cr 89Cr 84Cr 156.26Cr 11TCr 157.64Cr 1.05TCr 410.41Cr 5.18TCr 428.25Cr 419.24Cr 18TCr
Net Debt 1,91100Cr 130.79Cr 111.12Cr 101.69Cr 96Cr 179.04Cr 12TCr 180.62Cr 1.21TCr 470.23Cr 5.93TCr 490.67Cr 480.35Cr 20TCr 97TCr 67Cr 57Cr 52Cr 49Cr 91Cr 6.28TCr 92Cr 613.55Cr 239.18Cr 3.02TCr 249.57Cr 244.33Cr 10TCr
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
08/26/08 1,98,400.00 -2.02% 6,20,707
07/26/07 2,02,500.00 +4.01% 10,74,408
06/26/06 1,94,700.00 -1.57% 9,34,691
04/26/04 1,97,800.00 -1.35% 6,16,505
30/26/30 2,00,500.00 -1.72% 4,68,819
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
1,98,400.00KRW
Average target price
2,62,956.52KRW
Spread / Average Target
+32.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock